Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: An 11-year retrospective cohort study

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  McDermid, Joann M ^a   Hennig, Branwen J ^b,c   van der Sande, Marianne ^d,e   Hill, Adrian V S ^f   Whittle, Hilton C ^c   Jaye, Assan ^c   Prentice, Andrew M ^b,c  

^a Department of Obstetrics Gynecology   (United States)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; HAPTOGLOBIN; HEMOGLOBIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; TRANSFERRIN;

ADULT; ANEMIA; ARTICLE; BACTERIAL TRANSMISSION; BIOACCUMULATION; BLOOD ANALYSIS; CLINICAL INDICATOR; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE PREDISPOSITION; DNA DETERMINATION; FERRITIN BLOOD LEVEL; GENOTYPE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; INFECTION RISK; IRON BALANCE; IRON STORAGE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEROPREVALENCE; TRANSFERRIN BLOOD LEVEL;

ADULT; ALLELES; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; COINFECTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV INFECTIONS; HUMANS; IRON; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS; YOUNG ADULT;

EID: 84872975624     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-48     Document Type: Article

References (34)

1. World Health Organization Global tuberculosis report 2012 2012, Geneva, Switzerland: WHO Press, World Health Organization.
2. Centers for Disease Control CDC grand rounds: the TB/HIV syndemic. MMWR 2012, 61:484-489. Centers for Disease Control.
3. Banerjee S, Farhana A, Ehtesham NZ, Hasnain SE. Iron acquisition, assimilation and regulation in mycobacteria. Infect Genet Evol 2011, 11:825-838. 10.1016/j.meegid.2011.02.016, 21414421.
4. Jones CM, Niederweis M. Mycobacterium tuberculosis can utilize heme as an iron source. J Bacteriol 2011, 193:1767-1770. 10.1128/JB.01312-10, 3067660, 21296960.
5. Tullius MV, Harmston CA, Owens CP, Chim N, Morse RP, McMath LM, Iniguez A, Kimmey JM, Sawaya MR, Whitelegge JP, Horwitz MA, Goulding CW. Discovery and characterization of a unique mycobacterial heme acquisition system. Proc Natl Acad Sci U S A 2011, 108:5051-5056. 10.1073/pnas.1009516108, 3064333, 21383189.
6. Johnson EE, Srikanth CV, Sandgren A, Harrington L, Trebicka E, Wang L, Borregaard N, Murray M, Cherayil BJ. Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophages. FEMS Immunol Med Microbiol 2010, 58:138-145. 10.1111/j.1574-695X.2009.00622.x, 2822896, 19863663.
7. Spagnuolo MS, Cigliano L, Maresca B, Pugliese CR, Abrescia P. Identification of plasma haptoglobin forms which loosely bind hemoglobin. Biol Chem 2011, 392:371-376.
8. Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 2011, 434:365-381. 10.1042/BJ20101825, 3048577, 21348856.
9. Fritsche G, Nairz M, Theurl I, Mair S, Bellmann-Weiler R, Barton HC, Weiss G. Modulation of macrophage iron transport by Nramp1 (Slc11a1). Immunobiology 2008, 212:751-757.
10. Li X, Yang Y, Zhou F, Zhang Y, Lu H, Jin Q, Gao L. SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. PLoS One 2011, 6:e15831. 10.1371/journal.pone.0015831, 3026788, 21283567.
11. McDermid JM, van der Loeff MF, Jaye A, Hennig BJ, Bates C, Todd J, Sirugo G, Hill AV, Whittle HC, Prentice AM. Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction. Am J Clin Nutr 2009, 90:225-233. 10.3945/ajcn.2009.27709, 19474129.
12. Yano A, Yamamoto Y, Miyaishi S, Ishizu H. Haptoglobin genotyping by allele-specific polymerase chain reaction amplification. Acta Med Okayama 1998, 52:173-181.
13. van der Sande MA, van der Loeff MF S, Bennett RC, Dowling M, Aveika AA, Togun TO, Sabally S, Jeffries D, Adegbola RA, Sarge-Njie R, Jaye A, Corrah T, McConkey S, Whittle HC. Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2. AIDS 2004, 18:1933-1941. 10.1097/00002030-200409240-00009, 15353979.
14. Sahiratmadja E, Wieringa FT, van Crevel R, de Visser AW, Adnan I, Alisjahbana B, Slagboom E, Marzuki S, Ottenhoff TH, van de Vosse E, Marx JJ. Iron deficiency and NRAMP1 polymorphisms (INT4, D543N and 3'UTR) do not contribute to severity of anaemia in tuberculosis in the Indonesian population. Br J Nutr 2007, 98:684-690.
15. Karyadi E, Dolmans WM, West CE, Van Crevel R, Nelwan RH, Amin Z, Gross R, Van der Ven-Jongekrijg J, Van der Meer JW. Cytokines related to nutritional status in patients with untreated pulmonary tuberculosis in Indonesia. Asia Pac J Clin Nutr 2007, 16:218-226.
16. Mugusi FM, Mehta S, Villamor E, Urassa W, Saathoff E, Bosch RJ, Fawzi WW. Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Publ Health 2009, 9:409.
17. Saathoff E, Villamor E, Mugusi F, Bosch RJ, Urassa W, Fawzi WW. Anemia in adults with tuberculosis is associated with HIV and anthropometric status in Dar es Salaam, Tanzania. Int J Tuberc Lung Dis 2011, 15:925-932. 10.5588/ijtld.10.0477, 21682966.
18. Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, Klaver SM, Kroot JJ, van Tienoven D, Wetzels JF, Kiemeney LA, Sweep FC, den Heijer M, Swinkels DW. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 2011, 117:e218-e225. 10.1182/blood-2011-02-337907, 21527524.
19. Ramey G, Deschemin JC, Durel B, Canonne-Hergaux F, Nicolas G, Vaulont S. Hepcidin targets ferroportin for degradation in hepatocytes. Haematologica 2010, 95:501-504. 10.3324/haematol.2009.014399, 2833082, 19773263.
20. Gkouvatsos K, Papanikolaou G, Pantopoulos K. Regulation of iron transport and the role of transferrin. Biochim Biophys Acta 2011, 1820:188-202.
21. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 2009, 1790:682-693. 10.1016/j.bbagen.2008.08.006, 18786614.
22. Johnson EE, Wessling-Resnick M. Iron metabolism and the innate immune response to infection. Microbes Infect 2012, 14:207-216. 10.1016/j.micinf.2011.10.001, 22033148.
23. Cronje L, Edmondson N, Eisenach KD, Bornman L. Iron and iron chelating agents modulate Mycobacterium tuberculosis growth and monocyte-macrophage viability and effector functions. FEMS Immunol Med Microbiol 2005, 45:103-112. 10.1016/j.femsim.2005.02.007, 16051061.
24. Lounis N, Maslo C, Truffot-Pernot C, Grosset J, Boelaert RJ. Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis. Int J Tuberc Lung Dis 2003, 7:575-579.
25. Lounis N, Maslo C, Boelaert JR, Bonnafous P, Truffot-Pernot C, Baohong J, Grosset J. Impact of iron loading and iron chelation on murine tuberculosis. Clin Microbiol Infect 1999, 5:687-692.
26. Raghu B, Sarma GR, Venkatesan P. Effect of iron on the growth and siderophore production of mycobacteria. Biochem Mol Biol Int 1993, 31:341-348.
27. Schaible UE, Collins HL, Priem F, Kaufmann SH. Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med 2002, 196:1507-1513. 10.1084/jem.20020897, 2194267, 12461085.
28. Lee SW, Kang YA, Yoon YS, Um SW, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ. The prevalence and evolution of anemia associated with tuberculosis. J Korean Med Sci 2006, 21:1028-1032. 10.3346/jkms.2006.21.6.1028, 2721923, 17179681.
29. McDermid JM, Prentice AM. Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV. Clin Sci (Lond) 2006, 110:503-524.
30. Velez DR, Hulme WF, Myers JL, Stryjewski ME, Abbate E, Estevan R, Patillo SG, Gilbert JR, Hamilton CD, Scott WK. Association of SLC11A1 with tuberculosis and interactions with NOS2A and TLR2 in African-Americans and Caucasians. Int J Tuberc Lung Dis 2009, 13:1068-1076. 2902362, 19723394.
31. Hoal EG, Lewis LA, Jamieson SE, Tanzer F, Rossouw M, Victor T, Hillerman R, Beyers N, Blackwell JM, Van Helden PD. SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa. Int J Tuberc Lung Dis 2004, 8:1464-1471.
32. Fitness J, Floyd S, Warndorff DK, Sichali L, Malema S, Crampin AC, Fine PE, Hill AV. Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg 2004, 71:341-349.
33. de Wit E, van der Merwe L, van Helden PD, Hoal EG. Gene-gene interaction between tuberculosis candidate genes in a South African population. Mamm Genome 2011, 22:100-110. 10.1007/s00335-010-9280-8, 20799037.
34. Kasvosve I, Gomo ZA, Mvundura E, Moyo VM, Saungweme T, Khumalo H, Gordeuk VR, Boelaert JR, Delanghe JR, De Bacquer D, Gangaidzo IT. Haptoglobin polymorphism and mortality in patients with tuberculosis. Int J Tuberc Lung Dis 2000, 4:771-775.